Bill Status of SB0275  102nd General Assembly


Short Description:  INS-PRESCRIPTION DRUG BENEFITS

Senate Sponsors
Sen. Don Harmon - Laura Fine - John Connor and Adriane Johnson

Last Action
DateChamber Action
  4/16/2021SenateRule 3-9(a) / Re-referred to Assignments

Statutes Amended In Order of Appearance
215 ILCS 134/45.3 new


Synopsis As Introduced
Amends the Managed Care Reform and Patient Rights Act. Requires health insurance carriers that provide coverage for prescription drugs to ensure that, within service areas and levels of coverage specified by federal law, at least half of individual and group plans meet one or more of the following criteria: apply a pre-deductible and flat-dollar copayment structure to the entire drug benefit, limit a beneficiary's monthly out-of-pocket financial responsibility for prescription drugs to a specified amount, or limit a beneficiary's annual out-of-pocket financial responsibility for prescription drugs to a specified amount. Provides that all plans for prescription drugs offered under the amendatory Act must be clearly and appropriately named, marketed in the same manner as other plans offered by the health insurance carrier, and offered for purchase to any individual and group plan sponsor. Effective January 1, 2022.

Actions 
DateChamber Action
  2/19/2021SenateFiled with Secretary by Sen. Scott M. Bennett
  2/19/2021SenateFirst Reading
  2/19/2021SenateReferred to Assignments
  2/24/2021SenateAssigned to Insurance
  2/25/2021SenateAdded as Chief Co-Sponsor Sen. Laura Fine
  3/23/2021SenateAdded as Co-Sponsor Sen. Adriane Johnson
  4/16/2021SenateAdded as Chief Co-Sponsor Sen. John Connor
  4/16/2021SenateRule 3-9(a) / Re-referred to Assignments
  12/22/2022SenateChief Sponsor Changed to Sen. Don Harmon